These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 9350177

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of acute myelogenous leukemia and myelodysplastic syndromes.
    Estey EH.
    Semin Hematol; 1995 Apr; 32(2):132-51. PubMed ID: 7652581
    [No Abstract] [Full Text] [Related]

  • 23. [Intensive chemotherapy with autologous bone marrow transplantation: assessment and limits. What is its future?].
    Gisselbrecht C.
    Bull Cancer; 1995 Apr; 82 Suppl 1():51s-52s. PubMed ID: 7542944
    [No Abstract] [Full Text] [Related]

  • 24. Autologous bone marrow transplantation in first remission AML--its relative value.
    de Gast GC, Zwaan FE, Hagenbeek T, Verdonck LF, Löwenberg B.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468
    [No Abstract] [Full Text] [Related]

  • 25. Autologous stem cell transplantation (ASCT) in Hodgkin's disease: present status.
    Angelo M, Carella AM.
    Pathol Biol (Paris); 1993 Jan; 41(1):107-9. PubMed ID: 7686282
    [No Abstract] [Full Text] [Related]

  • 26. Acute myeloid leukemia and the position of autologous stem cell transplantation.
    Breems DA, Löwenberg B.
    Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
    [Abstract] [Full Text] [Related]

  • 27. Current progress in the treatment of adult acute leukemia in Japan.
    Ohno R.
    Jpn J Clin Oncol; 1993 Apr; 23(2):85-97. PubMed ID: 7685836
    [No Abstract] [Full Text] [Related]

  • 28. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
    Powles R, Treleaven J, Millar J, Gordon-Smith EC, Tiley C, Findlay M, Teo C, Duncombe A, Robinson G.
    Bone Marrow Transplant; 1991 Apr; 7 Suppl 2():9-10. PubMed ID: 1878737
    [No Abstract] [Full Text] [Related]

  • 29. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
    Hiddemann W.
    Dtsch Med Wochenschr; 2012 Nov; 137(45):2306. PubMed ID: 23111791
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
    Suciu S, Solbu G, Zittoun R, Hayat M, Willemze R, de Witte T, Mandelli F.
    Bone Marrow Transplant; 1991 Nov; 7 Suppl 2():34. PubMed ID: 1878707
    [No Abstract] [Full Text] [Related]

  • 33. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
    Ottmann OG, Bug G, Krauter J.
    Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
    [Abstract] [Full Text] [Related]

  • 34. [Prevention of myelotoxicity in a case of bone marrow transplantation using granulocyte-macrophage colony-stimulating factor along with ganciclovir].
    Reynoso Gómez E, Dueñas González A, Miranda López E, Sobrevilla Calvo P, Donis Hernández J, Texcocano Becerra J, Salinas Rojas V.
    Rev Invest Clin; 1996 Jul; 48(1):55-8. PubMed ID: 8815488
    [Abstract] [Full Text] [Related]

  • 35. G-CSF priming in acute myelogenous leukemia.
    Murashige N, Kami M, Takaue Y.
    N Engl J Med; 2003 Nov 20; 349(21):2071-2; author reply 2071-2. PubMed ID: 14627794
    [No Abstract] [Full Text] [Related]

  • 36. [Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].
    Zittoun R, Rio B, Delmer A, Vekhof A, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P.
    Nouv Rev Fr Hematol (1978); 1993 Feb 20; 35(1):15-6. PubMed ID: 8511034
    [No Abstract] [Full Text] [Related]

  • 37. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
    Bone Marrow Transplant; 1999 Sep 20; 24(5):467-72. PubMed ID: 10482929
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of leukemia: discussion].
    Nihon Naika Gakkai Zasshi; 1992 Jul 10; 81(7):1081-93. PubMed ID: 1383368
    [No Abstract] [Full Text] [Related]

  • 39. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
    Croockewit AJ, Koopmans PP, de Pauw BE.
    Clin Pharmacol Ther; 1996 Jan 10; 59(1):1-6. PubMed ID: 8549028
    [No Abstract] [Full Text] [Related]

  • 40. Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia.
    Adkins DR, Brown RA, DiPersio JF.
    J Clin Oncol; 1997 Feb 10; 15(2):862-3. PubMed ID: 9053516
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.